Skip to content

Sexual Dysfunction in Patients With Myofascial Pain Syndrome

Sexual Dysfunction in Patients With Myofascial Pain Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05727566
Enrollment
90
Registered
2023-02-14
Start date
2022-05-11
Completion date
2023-04-15
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome, Sexual Dysfunction

Keywords

sexual dysfunction, myofascial pain sydrome, pain

Brief summary

This study evaluates the frequency of sexual dysfunction in women with myofascial pain syndrome and its relationship with clinical parameters.

Detailed description

The frequency of sexual dysfunction in reproductive-aged married women with primary myofascial pain syndrome will be evaluated in a prospective, cross-sectional survey-type study. The medical history of each participant was obtained and they underwent a detailed physical examination. Sociodemographic and clinic characteristics of all participants (age, education, marital status, employment status, family structure, income status, Body Mass Index(BMI), disease duration, number of pregnancies, sleep quality, etc.) were recorded. Pain and fatigue levels of the patients were measured by the visual pain scale (VAS), mood states by the Beck depression index (BDI), sexual function of the participants was assessed by the 0-10 Visual Analog Scale (VAS) to assess the degree of importance of sexuality (the sexuality-importance score). In addition, weekly/monthly sexual intercourse frequency was asked to all participants (patient and control groups). The questionnaires were administered to all participants in a room where they were alone with a female physician, and a suitable environment was provided for the patients to fill out the questionnaire. Patients were assured of the confidentiality of their information. Only questions that were not understood by the patient were explained without guidance.

Interventions

OTHERvisual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

Sponsors

Konya Beyhekim Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Myofascial pain syndrome (\>3 months) was diagnosed in a female. * Being between the ages of 18 and 50, married, sexually active, and not menopausal * Volunteering to participate in the study, and being able to communicate easily.

Exclusion criteria

* a history of systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, etc.) * major psychiatric illness, mental retardation * uncontrollable respiratory system problems * endocrine diseases, neurological diseases * previous hysterectomy or vaginal surgery, a history of sexually transmitted diseases * urinary or anal incontinence * limited motion in the upper or lower extremities * Fibromyalgia * inflammatory rheumatic diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.) * cervical/lumbar radiculopathy or myelopathy * communication problems * pregnancy, lactation * taking estrogen therapy * use antidepressant, anxiolytic, and antiepileptic drugs * chronic alcohol users

Design outcomes

Primary

MeasureTime frameDescription
Sexuality-importance score11.05.2022-15.03.2023 (cross-sectional)Sexual function of the participants was assessed by the 0 (never mind)-10(very important) Visual Analog Scale (VAS) to assess the degree of importance of sexuality.
The frequency of sexual intercourse11.05.2022-15.03.2023 (cross-sectionalWeekly/monthly sexual intercourse frequency was asked of all participants.

Secondary

MeasureTime frameDescription
Visual analog scale (VAS pain/fatigue)11.05.2022 - 15.03.2023 (cross-sectional)All participants were assessed in terms of pain and fatigue levels by means of a visual analogue scale of 0-10 cm (VAS).
Beck depression index (BDI)11.05.2022 - 15.03.2023 (cross-sectional)In the assessment of depression severity, the Turkish version of the 21-item Beck Depression Inventory (BDI) was used, which is one of the most common psychometric tests used and a value of 0 to 3 is assigned for each answer to each item.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026